Insider Transactions

What CNS Pharmaceuticals Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

	3 months	12 months
Open-market buys	0	2
Sells	0	0
Total trades	1	3

Shares traded

	3 months	12 months
Acquired	0	9,100
Disposed	4,750	4,750
Net activity	−4,750	+4,350

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

All Buys Sells

Insider	Relation	Date	Transaction	Shares	Price	Value	Shares held
Levin Rami	CEO and President	Aug 14	Exercise / conversion · M	−4,750	—	—	4,750
Charles Faith L.	Director	May 18	Open-market buy · P	+7,100	$4.79	+$34K	7,100
Fisher Michal	Director	May 18	Open-market buy · P	+2,000	$5.00	+$10K	2,000
Downs Christopher	Chief Financial Officer	Feb 01	Open-market buy · P	+66,666	$0.30	+$20K	103,438
Evans Carl Anthony	Director	Feb 01	Open-market buy · P	+33,333	$0.30	+$10K	33,458
Gumulka Jerzy	Director	Feb 01	Open-market buy · P	+33,333	$0.30	+$10K	43,006
Climaco John M	Chief Executive Officer	Feb 01	Open-market buy · P	+166,666	$0.30	+$50K	215,676
Downs Christopher	Chief Financial Officer	Aug 22	Open-market buy · P	+27,000	$1.27	+$34.2K	36,772
Climaco John M	Chief Executive Officer	Aug 16	Open-market buy · P	+2,750	$1.80	+$4.94K	49,010
Downs Christopher	Chief Financial Officer	Apr 28	Exercise / conversion · M	+521	—	—	9,772
Climaco John M	Chief Executive Officer	Apr 28	Exercise / conversion · M	+1,250	—	—	46,260
Gumulka Jerzy	Director	Apr 19	Open-market buy · P	+2,500	$1.70	+$4.25K	9,673
Downs Christopher	Chief Financial Officer	Apr 17	Open-market buy · P	+3,100	$3.20	+$9.92K	9,251
Climaco John M	Chief Executive Officer	Apr 12	Open-market buy · P	+15,000	$0.69	+$10.4K	45,010
Gumulka Jerzy	Director	Apr 10	Open-market buy · P	+7,173	$0.74	+$5.31K	7,173
Priebe Waldemar	10% owner	Mar 28	Open-market sale · S	−10,000	$1.04	−$10.4K	156,807
Priebe Waldemar	10% owner	Mar 27	Open-market sale · S	−5,000	$1.09	−$5.45K	166,807
Priebe Waldemar	10% owner	Mar 24	Open-market sale · S	−5,000	$1.08	−$5.4K	171,807
Priebe Waldemar	10% owner	Mar 23	Open-market sale · S	−10,000	$1.08	−$10.8K	176,807
Priebe Waldemar	10% owner	Mar 22	Open-market sale · S	−5,000	$1.08	−$5.4K	186,807

Page 1 of 3 · showing the 20 most recent Sign up free to view all 41 transactions and filter by insider →

Comments